Company Filing History:
3 out of 4,554 
2 out of 1,631 
Years Active: 2013-2019
Title: Amir Goldkorn: Innovator in Cancer Detection
Introduction
Amir Goldkorn is a prominent inventor based in Beverly Hills, CA. He has made significant contributions to the field of cancer detection and diagnosis. With a total of 3 patents, his work focuses on innovative methods that enhance the accuracy and efficiency of cancer diagnostics.
Latest Patents
Goldkorn's latest patents include a groundbreaking method for cancer detection, diagnosis, and prognosis. This invention provides a method for diagnosing cancer and predicting disease outcomes or responses to therapy in patient samples. The method involves isolating a circulating tumor cell (CTC) from a sample using a parylene microfilter device. This device comprises a membrane filter made of a parylene substrate, featuring an array of holes with predetermined shapes and sizes. Additionally, the method includes detecting and quantifying telomerase activity in blood circulating tumor cells. The invention further outlines methods for utilizing live-captured cells in various applications.
Career Highlights
Throughout his career, Amir Goldkorn has worked with esteemed institutions such as the California Institute of Technology and the University of Southern California. His experience in these prestigious organizations has contributed to his expertise in cancer research and diagnostics.
Collaborations
Goldkorn has collaborated with notable colleagues, including Yu-Chong Tai and Tong Xu. These partnerships have fostered innovation and advancement in the field of cancer detection.
Conclusion
Amir Goldkorn's contributions to cancer detection and diagnosis exemplify the impact of innovative thinking in medical research. His patents and collaborations continue to pave the way for advancements in cancer diagnostics, ultimately benefiting patients and healthcare providers alike.